195 related articles for article (PubMed ID: 17461443)
1. Rising costs and hospital admissions for hepatocellular carcinoma in Portugal (1993-2005).
Marinho RT; Giria J; Moura MC
World J Gastroenterol; 2007 Mar; 13(10):1522-7. PubMed ID: 17461443
[TBL] [Abstract][Full Text] [Related]
2. The inpatient economic and mortality impact of hepatocellular carcinoma from 2005 to 2009: analysis of the US nationwide inpatient sample.
Mishra A; Otgonsuren M; Venkatesan C; Afendy M; Erario M; Younossi ZM
Liver Int; 2013 Sep; 33(8):1281-6. PubMed ID: 23710596
[TBL] [Abstract][Full Text] [Related]
3. Burden of burns in Portugal, 2000-2013: A clinical and economic analysis of 26,447 hospitalisations.
Santos JV; Oliveira A; Costa-Pereira A; Amarante J; Freitas A
Burns; 2016 Jun; 42(4):891-900. PubMed ID: 27133714
[TBL] [Abstract][Full Text] [Related]
4. An observational study of the direct costs related to hospital admissions, mortality and premature death associated with liver disease in Portugal.
Vitor S; Marinho RT; Gíria J; Velosa J
BMC Res Notes; 2016 Feb; 9():62. PubMed ID: 26843372
[TBL] [Abstract][Full Text] [Related]
5. Estimating the cost of hospital treatment for injuries using linked morbidity data.
Unwin E; Codde J
Aust N Z J Public Health; 1998 Aug; 22(5):624-6. PubMed ID: 9744221
[TBL] [Abstract][Full Text] [Related]
6. Differences in the use of health resources by Spanish and immigrant HIV-infected patients.
Velasco M; Castilla V; Guijarro C; Moreno L; Barba R; Losa JE
Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):458-62. PubMed ID: 22377495
[TBL] [Abstract][Full Text] [Related]
7. Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis.
Tapper EB; Catana AM; Sethi N; Mansuri D; Sethi S; Vong A; Afdhal NH
Cancer; 2016 Mar; 122(6):852-8. PubMed ID: 26716758
[TBL] [Abstract][Full Text] [Related]
8. Health care costs associated with hepatocellular carcinoma: a population-based study.
Thein HH; Isaranuwatchai W; Campitelli MA; Feld JJ; Yoshida E; Sherman M; Hoch JS; Peacock S; Krahn MD; Earle CC
Hepatology; 2013 Oct; 58(4):1375-84. PubMed ID: 23300063
[TBL] [Abstract][Full Text] [Related]
9. Incidence, duration and cost of futile treatment in end-of-life hospital admissions to three Australian public-sector tertiary hospitals: a retrospective multicentre cohort study.
Carter HE; Winch S; Barnett AG; Parker M; Gallois C; Willmott L; White BP; Patton MA; Burridge L; Salkield G; Close E; Callaway L; Graves N
BMJ Open; 2017 Oct; 7(10):e017661. PubMed ID: 29038186
[TBL] [Abstract][Full Text] [Related]
10. Mortality and hospital utilization for hepatocellular carcinoma in the United States.
Kim WR; Gores GJ; Benson JT; Therneau TM; Melton LJ
Gastroenterology; 2005 Aug; 129(2):486-93. PubMed ID: 16083705
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
[TBL] [Abstract][Full Text] [Related]
12. The lifetime cost of hepatocellular carcinoma : a claims data analysis from a medical centre in Taiwan.
Lang HC; Wu JC; Yen SH; Lan CF; Wu SL
Appl Health Econ Health Policy; 2008; 6(1):55-65. PubMed ID: 18774870
[TBL] [Abstract][Full Text] [Related]
13. Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan.
Nguang SH; Wu CK; Liang CM; Tai WC; Yang SC; Ku MK; Yuan LT; Wang JW; Tseng KL; Hung TH; Hsu PI; Wu DC; Chuah SK; Hsu CN
Int J Environ Res Public Health; 2018 Nov; 15(12):. PubMed ID: 30486324
[TBL] [Abstract][Full Text] [Related]
14. Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States.
Kaplan DE; Chapko MK; Mehta R; Dai F; Skanderson M; Aytaman A; Baytarian M; D'Addeo K; Fox R; Hunt K; Pocha C; Valderrama A; Taddei TH;
Clin Gastroenterol Hepatol; 2018 Jan; 16(1):106-114.e5. PubMed ID: 28756056
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular Carcinoma: A Decade of Hospitalizations and Financial Burden in the United States.
Jinjuvadia R; Salami A; Lenhart A; Jinjuvadia K; Liangpunsakul S; Salgia R
Am J Med Sci; 2017 Oct; 354(4):362-369. PubMed ID: 29078840
[TBL] [Abstract][Full Text] [Related]
16. Trends and predictors of outcomes after surgery for hepatocellular carcinoma: A nationwide population-based study in Taiwan.
Chiu CC; Wang JJ; Chen YS; Chen JJ; Tsai TC; Lai CC; Sun DP; Shi HY
Eur J Surg Oncol; 2015 Sep; 41(9):1170-8. PubMed ID: 26048295
[TBL] [Abstract][Full Text] [Related]
17. HIV disease burden, cost, and length of stay in Portuguese hospitals from 2000 to 2010: a cross-sectional study.
Catumbela E; Freitas A; Lopes F; Mendoza Mdel C; Costa C; Sarmento A; da Costa-Pereira A
BMC Health Serv Res; 2015 Apr; 15():144. PubMed ID: 25889920
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study).
Abergel A; Rotily M; Branchoux S; Akremi R; de Léotoing L; Vainchtock A; Gaudin AF
Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):340-348. PubMed ID: 26546175
[TBL] [Abstract][Full Text] [Related]
19. Rising total costs and mortality rates associated with admissions due to COPD exacerbations.
Molinari N; Chanez P; Roche N; Ahmed E; Vachier I; Bourdin A
Respir Res; 2016 Nov; 17(1):149. PubMed ID: 27842545
[TBL] [Abstract][Full Text] [Related]
20. Associated factors and cost of inappropriate hospital admissions and stays in a second-level hospital.
Soria-Aledo V; Carrillo-Alcaraz A; Campillo-Soto A; Flores-Pastor B; Leal-Llopis J; Fernández-Martín MP; Carrasco-Prats M; Aguayo-Albasini JL
Am J Med Qual; 2009; 24(4):321-32. PubMed ID: 19515942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
